A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...
Clinical Trials Arena on MSN20h
Moleculin Biotech begins dosing subjects in combination therapy trial for AMLUS-based pharmaceutical company Moleculin Biotech has begun dosing subjects in its Phase III MIRACLE trial of Annamycin with ...
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...
Leukemia is a broad term; there are actually several different types of this condition. It can be “acute — sudden onset” or “chronic — slow onset.” Leukemia is a blood cancer.
The Saskatchewan government announced $15 million in new funding Thursday to increase acute care capacity at Saskatoon City Hospital. In a news release Friday, the Saskatchewan Health Authority ...
The combination not only killed the leukemia cells, but also significantly reduced their infiltration into the bone marrow. Acute myeloid leukemia (AML) is an aggressive form of blood cancer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback